AAAAAA
Results:
1-18
|
Results: 18
Authors:
Rasmussen, T
Fink-Jensen, A
Sauerberg, P
Swedberg, MDB
Thomsen, C
Sheardown, MJ
Jeppesen, L
Calligaro, DO
DeLapp, NW
Whitesitt, C
Ward, JS
Shannon, HE
Bymaster, FP
Citation: T. Rasmussen et al., The muscarinic receptor agonist BuTAC, a novel potential antipsychotic, does not impair learning and memory in mouse passive avoidance, SCHIZOPHR R, 49(1-2), 2001, pp. 193-201
Authors:
Shannon, HE
Jones, CK
Li, DL
Peters, SC
Simmons, RMA
Iyengar, S
Citation: He. Shannon et al., Antihyperalgesic effects of the muscarinic receptor ligand vedaclidine in models involving central sensitization in rats, PAIN, 93(3), 2001, pp. 221-227
Authors:
Bymaster, FP
Carter, PA
Zhang, L
Falcone, JF
Stengel, PW
Cohen, ML
Shannon, HE
Gomeza, J
Wess, J
Felder, CC
Citation: Fp. Bymaster et al., Investigations into the physiological role of muscarinic M-2 and M-4 muscarinic and M-4 receptor subtypes using receptor knockout mice, LIFE SCI, 68(22-23), 2001, pp. 2473-2479
Authors:
Perry, KW
Nisenbaum, LK
George, CA
Shannon, HE
Felder, CC
Bymaster, FP
Citation: Kw. Perry et al., The muscarinic agonist xanomeline increases monoamine release and immediate early gene expression in the rat prefrontal cortex, BIOL PSYCHI, 49(8), 2001, pp. 716-725
Authors:
Shannon, HE
Lutz, EA
Citation: He. Shannon et Ea. Lutz, Yohimbine produces antinociception in the formalin test in rats: involvement of serotonin(1A) receptors, PSYCHOPHAR, 149(1), 2000, pp. 93-97
Authors:
Shannon, HE
Rasmussen, K
Bymaster, FP
Hart, JC
Peters, SC
Swedberg, MDB
Jeppesen, L
Sheardown, MJ
Sauerberg, P
Fink-Jensen, A
Citation: He. Shannon et al., Xanomeline, an M-1/M-4 preferring muscarinic cholinergic receptor agonist,produces antipsychotic-like activity in rats and mice, SCHIZOPHR R, 42(3), 2000, pp. 249-259
Authors:
Shannon, HE
Lutz, EA
Citation: He. Shannon et Ea. Lutz, Effects of the I-1 imidazoline/alpha(2)-adrenergic receptor agonist moxonidine in comparison with clonidine in the formalin test in rats, PAIN, 85(1-2), 2000, pp. 161-167
Authors:
Womer, DE
Shannon, HE
Citation: De. Womer et He. Shannon, Reversal of pertussis toxin-induced thermal allodynia by muscarinic cholinergic agonists in mice, NEUROPHARM, 39(12), 2000, pp. 2499-2504
Authors:
Womer, DE
Shannon, HE
Citation: De. Womer et He. Shannon, Pharmacologic reversal of pertussis toxin-induced thermal allodynia in mice, NEUROPHARM, 39(10), 2000, pp. 1732-1739
Authors:
Jones, CK
Shannon, HE
Citation: Ck. Jones et He. Shannon, Muscarinic cholinergic modulation of prepulse inhibition of the acoustic startle reflex, J PHARM EXP, 294(3), 2000, pp. 1017-1023
Authors:
Rasmussen, T
Sauerberg, P
Nielsen, EB
Swedberg, MDB
Thomsen, C
Sheardown, MJ
Jeppesen, L
Calligaro, DO
DeLapp, NW
Whitesitt, C
Ward, JS
Shannon, HE
Bymaster, FP
Fink-Jensen, A
Citation: T. Rasmussen et al., Muscarinic receptor agonists decrease cocaine self-administration rates indrug-naive mice, EUR J PHARM, 402(3), 2000, pp. 241-246
Authors:
Jones, CK
Shannon, HE
Citation: Ck. Jones et He. Shannon, Effects of scopolamine in comparison with apomorphine and phencyclidine onprepulse inhibition in rats, EUR J PHARM, 391(1-2), 2000, pp. 105-112
Authors:
Brodkin, J
Shannon, HE
Citation: J. Brodkin et He. Shannon, Communicating synergism in drug combination studies, ARZNEI-FOR, 50(8), 2000, pp. 765-767
Authors:
Sawyer, BD
Bymaster, FP
Calligaro, DO
Falcone, J
Mitch, CH
Ward, JS
Whitesitt, C
Shannon, HE
Citation: Bd. Sawyer et al., Direct pharmacological comparison of the muscarinic receptors mediating relaxation and contraction in the rabbit thoracic aorta, GEN PHARM, 32(4), 1999, pp. 445-452
Authors:
Bymaster, FP
Shannon, HE
Rasmussen, K
DeLapp, NW
Ward, JS
Calligaro, DO
Mitch, CH
Whitesitt, C
Ludvigsen, TS
Sheardown, M
Swedberg, M
Rasmussen, T
Olesen, PH
Jeppesen, L
Sauerberg, P
Fink-Jensen, A
Citation: Fp. Bymaster et al., Potential role of muscarinic receptors in schizophrenia, LIFE SCI, 64(6-7), 1999, pp. 527-534
Authors:
Shannon, HE
Hart, JC
Bymaster, FP
Calligaro, DO
Delapp, NW
Mitch, CH
Ward, JS
Fink-Jensen, A
Sauerberg, P
Jeppesen, L
Sheardown, MJ
Swedberg, MDB
Citation: He. Shannon et al., Muscarinic receptor agonists, like dopamine receptor antagonist antipsychotics, inhibit conditioned avoidance response in rats, J PHARM EXP, 290(2), 1999, pp. 901-907
Authors:
Jeppesen, L
Olesen, PH
Hansen, L
Sheardown, MJ
Thomsen, C
Rasmussen, T
Jensen, AF
Christensen, MS
Rimvall, K
Ward, JS
Whitesitt, C
Calligaro, DO
Bymaster, FP
Delapp, NW
Felder, CC
Shannon, HE
Sauerberg, P
Citation: L. Jeppesen et al., 1-(1,2,5-thiadiazol-4-yl)-4-azatricyclo[2.2.1.0(2,6)]heptanes as new potent muscarinic M-1 agonists: Structure-activity relationship for 3-aryl-2-propyn-1-yloxy and 3-aryl-2-propyn-1-ylthio derivatives, J MED CHEM, 42(11), 1999, pp. 1999-2006
Authors:
Fink-Jensen, A
Kristensen, P
Shannon, HE
Calligaro, DO
Delapp, NW
Whitesitt, C
Ward, JS
Thomsen, C
Rasmusseen, T
Sheardown, MJ
Jeppesen, L
Sauerberg, P
Bymaster, FP
Citation: A. Fink-jensen et al., Muscarinic agonists exhibit functional dopamine antagonism in unilaterally6-OHDA lesioned rats, NEUROREPORT, 9(15), 1998, pp. 3481-3486
Risultati:
1-18
|